INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

306 studies · page 12 of 13

2011 / Meta-analysis of prospective cohort studies

Higher dietary potassium intake was linked to a significantly lower risk of stroke in a meta-analysis of prospective studies.

Researchers performed a meta-analysis of prospective cohort studies published from 1966 to December 2009 with at least 4 years of follow-up to assess habitual potassium intake and cardiovascular outcomes. Across 15 cohort samples involving 247,510 participants, a 1.64-g (42 mmol) per day higher potassium intake was associated with a 21% lower risk of stroke (RR: 0.79; 95% CI: 0.68 to 0.90; p = 0.0007). Trends toward lower risks of CHD and total CVD reached statistical significance in sensitivity analyses after excluding a single cohort (RR: 0.93; 95% CI: 0.87 to 0.99 for CHD, and RR: 0.74; 95% CI: 0.60 to 0.91 for total CVD).

Shows an association, not proof of cause and effect.

D'Elia L, Barba G, Cappuccio FP, et al. J Am Coll Cardiol, 2011. PMID 21371638

2011 / Systematic review and meta-analysis of clinical trials and epidemiological studies

Mediterranean diet is linked to lower metabolic syndrome risk and improved cardiometabolic markers

A meta-analysis of 50 studies with 534,906 participants examined Mediterranean diet adherence. Combined prospective studies and trials showed adherence was associated with reduced metabolic syndrome risk (log hazard ratio: -0.69, 95% CI: -1.24 to -1.16). Clinical trials showed favorable changes in waist circumference (-0.42 cm, 95% CI: -0.82 to -0.02), HDL cholesterol (1.17 mg/dl, 95% CI: 0.38 to 1.96), triglycerides (-6.14 mg/dl, 95% CI: -10.35 to -1.93), systolic blood pressure (-2.35 mm Hg, 95% CI: -3.51 to -1.18), diastolic readings (-1.58 mm Hg, 95% CI: -2.02 to -1.13), and blood sugar (-3.89 mg/dl, 95% CI: -5.84 to -1.95).

NANO counterpoint →

Kastorini CM, Milionis HJ, Esposito K, et al. J Am Coll Cardiol, 2011. PMID 21392646

2011 / Meta-analysis of controlled human trials

Tea consumption improves flow-mediated dilation compared to placebo in controlled human intervention trials.

A meta-analysis evaluated nine controlled intervention studies with 15 arms testing the effect of tea on brachial artery flow-mediated dilation. Tea intake increased flow-mediated dilation by an absolute 2.6% of arterial diameter versus placebo (95% CI: 1.8 to 3.3%, P < 0.001) at a median dose of 500 mL daily. Significant heterogeneity was detected among the included trials, which was partially attributed to the position of the measurement cuff.

Ras RT, Zock PL, Draijer R PLoS One, 2011. PMID 21394199

2011 / Meta-analysis of 30 research articles (126 clinical studies)

Beta-glucan intake showed significant inverse relations with total and LDL cholesterol; a 3-g/d dose was sufficient to decrease total cholesterol.

A meta-analysis evaluated 30 research articles yielding 126 clinical studies on the relation between oat and barley β-glucan and blood lipids and glucose. Significant inverse relations were found for total cholesterol (-0.60 mmol/L, 95% CI -0.85 to -0.34) and LDL (-0.66 mmol/L, 95% CI -0.96 to -0.36), with changes in triglycerides (-0.04 mmol/L, 95% CI -0.15 to 0.07) and HDL (0.03 mmol/L, 95% CI -0.06 to 0.13). Blood glucose level showed a significant change (-2.58 mmol/L, 95% CI -3.22 to -1.84), but heterogeneity was high (I^2 = 97%, tau^2 = 5.88). A dose-response model indicated 3 g/d of oat or barley β-glucan is sufficient to decrease blood cholesterol, while effects on blood glucose remain inconclusive.

Tiwari U, Cummins E Nutrition, 2011. PMID 21470820

2011 / Meta-analysis of randomized controlled trials

Calcium supplements with or without vitamin D increased cardiovascular event risk.

A reanalysis of the WHI trial and an updated meta-analysis evaluated calcium supplements with or without vitamin D. Across eight trials and WHI participants not taking personal supplements, calcium allocation increased myocardial infarction risk (RR 1.24, 95% CI 1.07-1.45) and composite myocardial infarction or stroke (RR 1.15, 95% CI 1.03-1.27). Trials combining calcium and vitamin D similarly increased myocardial infarction risk (RR 1.21, 95% CI 1.01-1.44).

Bolland MJ, Grey A, Avenell A, et al. BMJ, 2011. PMID 21505219

2011 / Systematic review

Human evidence is currently insufficient to recommend resveratrol supplements beyond dietary intake levels.

A systematic review assessed published research to formulate recommendations regarding resveratrol intake for human health. The authors determined that human evidence was insufficient to support resveratrol administration beyond amounts typically supplied by dietary sources. Although experimental animal studies suggested potential benefits for diabetes, heart disease, and various cancers, clinical trials in humans were deemed necessary before recommending therapeutic dosing.

Vang O, Ahmad N, Baile CA, et al. PLoS One, 2011. PMID 21698226

2011 / Meta-analysis of randomized controlled trials

Prediabetes interventions prevented diabetes but did not reduce total or cardiovascular mortality

A meta-analysis of 10 randomized trials encompassing 23,152 participants followed for an average of 3.75 years evaluated prediabetes therapies. Interventions reduced diabetes incidence versus controls (risk ratio 0.83, 95% CI 0.80-0.86), with non-drug approaches showing superior efficacy to drug treatments (0.52 vs 0.70, P < 0.05). However, no differences appeared for all-cause mortality (0.96, 0.84-1.10) or cardiovascular death (1.04, 0.61-1.78), while stroke risk showed a borderline reduction (0.76, 0.58-0.99).

Hopper I, Billah B, Skiba M, et al. Eur J Cardiovasc Prev Rehabil, 2011. PMID 21878448

2011 / Meta-analysis of randomized controlled trials

Lifestyle modifications improved erectile function scores in men with erectile dysfunction

A meta-analysis examined 6 randomized controlled trials totaling 740 men assessing cardiovascular risk reduction and lifestyle changes on erectile dysfunction. Combined interventions improved sexual function scores by a weighted mean difference of 2.66 (95% CI, 1.86-3.47). In the 4 trials examining lifestyle interventions alone without statins (n = 597), scores similarly improved by a weighted mean difference of 2.40 (95% CI, 1.19-3.61).

Gupta BP, Murad MH, Clifton MM, et al. Arch Intern Med, 2011. PMID 21911624

2010 / Meta-analysis of prospective cohorts

Dietary saturated fat intake was not associated with cardiovascular disease or stroke risk.

A meta-analysis of 21 prospective cohort studies tracked 347,747 participants over 5 to 23 years, documenting 11,006 cases of coronary heart disease or stroke. Comparing extreme intake quantiles, saturated fat was not associated with coronary heart disease (RR 1.07, 95% CI: 0.96 to 1.19), stroke (RR 0.81, 95% CI: 0.62 to 1.05), or cardiovascular disease (RR 1.00, 95% CI: 0.89 to 1.11).

Shows an association, not proof of cause and effect.

Siri-Tarino PW, Sun Q, Hu FB, et al. Am J Clin Nutr, 2010. PMID 20071648

2010 / Quantitative review and linear regression of intervention trials

Industrial trans fatty acids, ruminant trans fatty acids, and CLA all increase the plasma LDL to HDL cholesterol ratio when replacing cis-monounsaturated fats.

Researchers analyzed 39 intervention trials covering 29 treatments with industrial trans fatty acids, 6 with ruminant trans fatty acids, and 17 with conjugated linoleic acid (CLA), calculating effects when isocalorically replacing cis-monounsaturated fatty acids. In linear regression analysis, each 1% of dietary energy from industrial trans fatty acids increased the LDL to HDL ratio by 0.055 (95% CI: 0.044-0.066). The ratio increased by 0.038 (95% CI: 0.012-0.065) for ruminant trans fatty acids and by 0.043 (95% CI: 0.012-0.074) for CLA. The differences compared with industrial trans fatty acids were not statistically significant (p = 0.37 for ruminant; p = 0.99 for CLA).

Brouwer IA, Wanders AJ, Katan MB PLoS One, 2010. PMID 20209147

2010 / Meta-analysis of cohort studies

Higher brachial flow-mediated dilatation is associated with a lower risk of cardiovascular events.

A meta-analysis analyzed 14 cohort studies to evaluate the link between brachial artery flow-mediated dilatation and future cardiovascular events. Across 5,547 participants, every 1% increase in flow-mediated dilatation was associated with a lower risk of cardiovascular events (adjusted pooled RR 0.87, 95% CI, 0.83-0.91). This association remained consistent across all subgroups, though heterogeneity in study quality and potential publication bias were noted.

Shows an association, not proof of cause and effect.

Inaba Y, Chen JA, Bergmann SR Int J Cardiovasc Imaging, 2010. PMID 20339920

2010 / Pooled analysis of 25 intervention trials

A pooled analysis of 25 trials found that consuming an average of 67 g of nuts daily significantly improved blood lipid levels in a dose-related manner.

Researchers pooled individual primary data from 25 intervention trials involving 583 participants to assess the effects of nut consumption on blood lipid levels. A mean daily intake of 67 g of nuts resulted in significant estimated mean reductions in total cholesterol (10.9 mg/dL [5.1%]), LDL-C (10.2 mg/dL [7.4%]), LDL-C to HDL-C ratio (0.22 [8.3%]), and total cholesterol to HDL-C ratio (0.24 [5.6%]) (all P < .001). Triglycerides fell by 20.6 mg/dL (10.2%) only among participants with baseline triglycerides of at least 150 mg/dL (P < .05). Effects were dose-related and consistent across nut types, with greater lipid-lowering benefits observed in individuals with higher baseline LDL-C, lower body mass index, and those consuming Western diets.

Sabaté J, Oda K, Ros E Arch Intern Med, 2010. PMID 20458092

2010 / Systematic review and meta-analysis of prospective cohort studies

Greater adherence to the Mediterranean diet was associated with lower rates of overall mortality and major chronic diseases.

An updated meta-analysis evaluated prospective cohort studies up to June 2010, incorporating seven recent studies covering overall mortality, cardiovascular events, cancer, and neurodegenerative diseases. A 2-point increase in adherence to the Mediterranean diet was associated with a significant reduction of overall mortality (RR = 0.92; 95% CI: 0.90, 0.94), cardiovascular incidence or mortality (RR = 0.90; 95% CI: 0.87, 0.93), cancer incidence or mortality (RR = 0.94; 95% CI: 0.92, 0.96), and neurodegenerative diseases (RR = 0.87; 95% CI: 0.81, 0.94). Meta-regression revealed that sample size significantly influenced the estimated association for overall mortality.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Sofi F, Abbate R, Gensini GF, et al. Am J Clin Nutr, 2010. PMID 20810976

2010 / Systematic review of observational studies

A systematic review found limited evidence linking occupational sitting to health risks, though prospective studies showed links with diabetes and mortality.

Researchers systematically reviewed 43 papers (21% cross-sectional, 14% case-control, 65% prospective) examining associations between occupational sitting and various health risks. Half of the cross-sectional studies showed a positive association with BMI, but prospective studies did not confirm this. Some case-control evidence showed a positive link with cancer, but prospective studies generally did not support it; however, the majority of prospective studies found occupational sitting was associated with higher risks of diabetes mellitus and mortality. Overall, limited evidence supported a positive relationship, with heterogeneity in designs, measures, and findings precluding definitive conclusions.

Shows an association, not proof of cause and effect.

van Uffelen JG, Wong J, Chau JY, et al. Am J Prev Med, 2010. PMID 20837291

2009 / Meta-analysis of randomized controlled trials

Psyllium significantly lowered total and LDL cholesterol in a dose- and time-dependent manner in people with mild-to-moderate hypercholesterolemia.

A meta-analysis of 21 randomized placebo-controlled trials examined the effects of psyllium (3.0-20.4 g/day for >2 weeks) on serum lipids in mild-to-moderate hypercholesterolemia. Compared with placebo, psyllium reduced serum total cholesterol by 0.375 mmol/l (95% CI: 0.257-0.494 mmol/l) and LDL cholesterol by 0.278 mmol/l (95% CI: 0.213-0.312 mmol/l). Random-effects meta-regression identified a significant dose-response relationship between psyllium intake and reductions in both total and LDL cholesterol, as well as a time-dependent effect indicating total cholesterol was reduced more quickly than LDL cholesterol.

Wei ZH, Wang H, Chen XY, et al. Eur J Clin Nutr, 2009. PMID 18985059

2009 / Meta-analysis of randomized controlled trials

Phytosterols lower LDL cholesterol in a dose-dependent manner, with a mean 2.15 g daily dose reducing LDL-C by 8.8%.

A meta-analysis of 84 randomized controlled trials (141 trial arms) evaluated the continuous dose-response relationship of phytosterols on LDL-cholesterol (LDL-C). A mean daily dose of 2.15 g of phytosterols reduced LDL-C by 0.34 mmol/L (95% CI: -0.36, -0.31) or 8.8% (95% CI: -9.4, -8.3). Higher baseline LDL-C resulted in greater absolute reductions, while plant sterols versus stanols, fat-based versus non-fat-based foods, and dairy versus nondairy formats showed no significant differences. A larger effect was observed with solid foods than liquid foods only at doses >2 g/d, and single daily intakes tended to have slightly lower efficacy than multiple intakes (P = 0.054).

Demonty I, Ras RT, van der Knaap HC, et al. J Nutr, 2009. PMID 19091798

2009 / Collaborative pooled analysis of prospective studies

Mortality was lowest at a BMI of about 22.5–25 kg/m², with each 5 kg/m² increase above this range linked to about 30% higher overall mortality.

Collaborative analyses of 57 prospective studies with 894,576 participants evaluated baseline BMI and mortality, excluding the first 5 years of follow-up (leaving 66,552 deaths of known cause). In both sexes, mortality was lowest at about 22.5-25 kg/m². Above this range, each 5 kg/m² higher BMI was associated with approximately 30% higher overall mortality (HR 1.29 [95% CI 1.27-1.32]), including higher vascular (HR 1.41), diabetic (HR 2.16), renal (HR 1.59), hepatic (HR 1.82), neoplastic (HR 1.10), and respiratory mortality (HR 1.20). Below 22.5-25 kg/m², BMI was inversely associated with overall mortality, primarily due to strong inverse associations with respiratory disease and lung cancer, which were much stronger in smokers.

Shows an association, not proof of cause and effect.

Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Lancet, 2009. PMID 19299006

2009 / Systematic review and meta-analysis

Diets enriched with walnuts reduce total and LDL cholesterol in short-term trials

Thirteen trials comprising 365 participants evaluated diets providing 10% to 24% of calories from walnuts over 4 to 24 weeks. Walnut-supplemented diets significantly decreased circulating total cholesterol by a weighted mean difference of -10.3 mg/dL and LDL by -9.2 mg/dL (both P < 0.001) compared with control diets. Walnut intake had no significant effect on HDL cholesterol, triglycerides, body weight, or body mass index.

Banel DK, Hu FB Am J Clin Nutr, 2009. PMID 19458020

2009 / Systematic review and meta-analysis

Omega-3 dietary supplements reduce cardiovascular deaths and nonfatal events in randomized trials

A systematic review evaluated 11 randomized placebo-controlled trials including 39,044 individuals followed for an average of 2.2 years. Supplementation with EPA and DHA (mean 1.8 g/day) reduced cardiovascular fatalities (OR 0.87, 95% CI 0.79-0.95), sudden deaths from cardiac causes (OR 0.87, 95% CI 0.76-0.99), total mortality (OR 0.92, 95% CI 0.85-0.99), and nonfatal vascular events (OR 0.92, 95% CI 0.85-0.99). Mortality benefits occurred predominantly in high-risk groups, and daily dose did not correlate with outcomes.

NANO counterpoint →

Marik PE, Varon J Clin Cardiol, 2009. PMID 19609891

2008 / Systematic review and meta-analysis of prospective observational cohort studies

Positive psychological well-being was linked to reduced mortality in both healthy and diseased populations.

Researchers meta-analyzed prospective observational cohort studies examining positive psychological well-being and mortality up to January 2008. Positive psychological well-being was associated with reduced mortality in healthy populations (combined HR = 0.82; 95% CI = 0.76-0.89; p < .001) and diseased populations (combined HR = 0.98; 95% CI = 0.95-1.00; p = .030). Protective associations remained independent of negative affect, and in healthy populations, well-being was significantly linked to reduced cardiovascular mortality. Authors noted indications of publication bias, though fail-safe numbers were large (2444 for healthy, 1397 for disease populations).

Shows an association, not proof of cause and effect.

Chida Y, Steptoe A Psychosom Med, 2008. PMID 18725425

2008 / Meta-analysis of randomized controlled trials

Plant sterol-containing products significantly reduced LDL cholesterol concentrations compared with placebo in a meta-analysis of 59 RCTs.

A meta-analysis of 59 randomized clinical trials evaluated the effect of plant sterol-enriched products on LDL cholesterol levels. Compared with placebo, plant sterol-containing products reduced LDL levels by 0.31 mmol/L (95% CI, -0.35 to -0.27, P < 0.0001), though significant between-trial heterogeneity was observed (P < 0.0001). Greater reductions occurred in individuals with high baseline LDL levels and when sterols were incorporated into fat spreads, mayonnaise, salad dressing, milk, and yoghurt compared to other foods; a single morning dose did not produce a significant effect.

Abumweis SS, Barake R, Jones PJ Food Nutr Res, 2008. PMID 19109655

2007 / Pooled analysis of 5 community programs

A 30-day community lifestyle program was associated with reductions in coronary risk factors

Researchers analyzed pooled pre- and post-intervention data from five community-based cohorts participating in the Coronary Health Improvement Project. The 30-day curriculum instructed individuals to optimize diet, stop smoking, and walk 30 minutes daily. Significant decreases occurred in total cholesterol, LDL, triglycerides, fasting glucose, blood pressure, and body weight, with the largest shifts observed in participants starting at highest risk.

Englert HS, Diehl HA, Greenlaw RL, et al. Prev Med, 2007. PMID 17383717

2007 / Meta-analysis of prospective cohort studies

Controlling for abstainer bias suggests moderate alcohol confers no mortality benefit

A meta-analysis investigated prospective mortality studies evaluating light or moderate alcohol intake. The authors noted that categorizing former or occasional drinkers who quit due to age or illness as abstainers introduced systematic error. Prospective studies that avoided contaminating the abstainer group showed abstainers and light or moderate drinkers experienced equal risks of all-cause and coronary heart disease mortality.

Shows an association, not proof of cause and effect.

Fillmore KM, Stockwell T, Chikritzhs T, et al. Ann Epidemiol, 2007. PMID 17478320

2007 / Systematic review and meta-analysis of randomized controlled trials

Low glycaemic index or load diets led to significantly greater reductions in weight, body fat, and cholesterol compared to higher GI/GL or control diets.

A systematic review and meta-analysis of six randomized controlled trials (202 participants, interventions lasting 5 weeks to 6 months) evaluated low glycaemic index or load diets (LGI) compared to higher GI/GL or other diets (Cdiet) for overweight and obesity. LGI produced significantly greater decreases in body mass (WMD -1.1 kg, 95% CI -2.0 to -0.2), total fat mass (WMD -1.1 kg, 95% CI -1.9 to -0.4), and BMI (WMD -1.3, 95% CI -2.0 to -0.5; all P < 0.05). Significant improvements were also observed for total cholesterol (WMD -0.22 mmol/L, 95% CI -0.43 to -0.02) and LDL-cholesterol (WMD -0.24 mmol/L, 95% CI -0.44 to -0.05). No included study reported on adverse effects, mortality, or quality of life data.

Thomas DE, Elliott EJ, Baur L Cochrane Database Syst Rev, 2007. PMID 17636786